Transduction of bone marrow cells by the AdZ.F(pK7) modified adenovirus demonstrates preferential gene transfer in myeloma cells.
暂无分享,去创建一个
B. Quesnel | P. Fenaux | R. Vereecque | F. Bauters | I. Kovesdi | T. Wickham | T. Facon | D. Hétuin | R. Gonzalez
[1] M. Dewhirst,et al. Enhancement of radiotherapy by hyperthermia-regulated gene therapy. , 2000, International journal of radiation oncology, biology, physics.
[2] B. Quesnel,et al. Increased gene transfer in acute myeloid leukemic cells by an adenovirus vector containing a modified fiber protein , 1999, Gene Therapy.
[3] K. Anderson,et al. Adenovirus vector-based purging of multiple myeloma cells. , 1998, Blood.
[4] B. Lord,et al. CD34+AC133+ Cells Isolated from Cord Blood are Highly Enriched in Long‐Term Culture‐Initiating Cells, NOD/SCID‐Repopulating Cells and Dendritic Cell Progenitors , 1998, Stem cells.
[5] G. Dranoff,et al. Cancer gene therapy: connecting basic research with clinical inquiry. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] W. Dalton,et al. Broadened clinical utility of gene gun-mediated, granulocyte-macrophage colony-stimulating factor cDNA-based tumor cell vaccines as demonstrated with a mouse myeloma model. , 1998, Human gene therapy.
[7] B. Barlogie,et al. Syndecan-1 is a multifunctional regulator of myeloma pathobiology: control of tumor cell survival, growth, and bone cell differentiation. , 1998, Blood.
[8] S. Shammah,et al. Adenovirus vectors for gene transduction into mobilized blood CD34+ cells , 1998, Gene Therapy.
[9] F. Graham,et al. In vivo adenoviral-mediated gene transfer of interleukin-2 in cutaneous plasmacytoma. , 1998, Blood.
[10] J. Bergelson,et al. The Murine CAR Homolog Is a Receptor for Coxsackie B Viruses and Adenoviruses , 1998, Journal of Virology.
[11] F. Paillard. Immuno-Gene Therapy for Myeloma Using Cytokines Suicide Genes Against Brain Tumors , 1998 .
[12] S. Rudikoff,et al. Interleukin-2-mediated modulation of plasma cell tumor growth in a model of multiple myeloma. , 1998, Human gene therapy.
[13] S. Gallinger,et al. Efficient adenovirus-mediated gene expression in malignant human plasma cells: relative lymphoid cell resistance. , 1998, Experimental hematology.
[14] J. Kearney,et al. AC133, a novel marker for human hematopoietic stem and progenitor cells. , 1997, Blood.
[15] R. Warnke,et al. A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. , 1997, Blood.
[16] D. Brough,et al. Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins , 1997, Journal of virology.
[17] B. Trapnell,et al. Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy , 1996, Journal of virology.
[18] D. Brough,et al. Adenovirus targeted to heparan-containing receptors increases its gene delivery efficiency to multiple cell types , 1996, Nature Biotechnology.
[19] H. Haddada,et al. Differential efficacy of adenoviral mediated gene transfer into cells from hematological cell lines and fresh hematological malignancies. , 1996, Leukemia.
[20] J. Woodliff,et al. Expression of syndecan regulates human myeloma plasma cell adhesion to type I collagen , 1993 .